Last $4.29 USD
Change Today +0.01 / 0.23%
Volume 48.1K
CO On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

china cord blood corp (CO) Snapshot

Open
$4.29
Previous Close
$4.28
Day High
$4.32
Day Low
$4.25
52 Week High
03/7/14 - $4.85
52 Week Low
05/17/13 - $2.75
Market Cap
313.2M
Average Volume 10 Days
138.8K
EPS TTM
$0.24
Shares Outstanding
73.0M
EX-Date
--
P/E TM
17.9x
Dividend
--
Dividend Yield
--
Current Stock Chart for CHINA CORD BLOOD CORP (CO)

china cord blood corp (CO) Related Bloomberg News

View More Bloomberg News

china cord blood corp (CO) Related Businessweek News

No Related Businessweek News Found

china cord blood corp (CO) Details

China Cord Blood Corporation, together with its subsidiaries, primarily engages in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. The company provides cord blood testing, processing, and storage services under the direction of subscribers; laboratory testing and hematopoietic stem cell services; and tests, processes, and stores donated cord blood, as well as offers matching services. As of March 31, 2013, it had three operating cord blood banks in the Beijing municipality, the Guangdong province, and the Zhejiang province. China Cord Blood Corporation is based in Central, Hong Kong.

890 Employees
Last Reported Date: 07/31/13

china cord blood corp (CO) Top Compensated Officers

Chief Executive Officer, Director and Member ...
Total Annual Compensation: $509.8K
Chief Financial Officer, Chief Accounting Off...
Total Annual Compensation: $509.8K
Chief Executive Officer of Guangdong Division...
Total Annual Compensation: $278.2K
Chief Executive Officer of Beijing Division
Total Annual Compensation: $197.1K
Chief Technology Officer
Total Annual Compensation: $165.8K
Compensation as of Fiscal Year 2013.

china cord blood corp (CO) Key Developments

Cordlife Group Limited Signs Strategic Alliance Agreement with CordLabs Asia Pte. Ltd and China Cord Blood Corporation to Expand Umbilical Cord Tissue Storage Services

Cordlife Group Limited announced that it has extended its strategic alliance and co- operation with CordLabs Asia Pte. Ltd. (CAP) in relation to the provision of human postnatal umbilical cord tissue storage services to certain territories in the People's Republic of China. Pursuant to the strategic alliance, Cordlife will work with CAP and China Cord Blood Corporation (CCBC) in relation to the provision of the Services on an exclusive basis.

China Cord Blood Corporation Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2013

China Cord Blood Corporation reported unaudited consolidated earnings results for the third quarter and nine months ended December 31, 2013. For the quarter, the company reported revenue of RMB 150,586,000 against RMB 149,320,000 a year ago. Operating income was RMB 65,743,000 against RMB 67,125,000 a year ago. Income before income tax was RMB 49,236,000 against RMB 48,537,000 a year ago. Net income attributable to the company was RMB 34,554,000 or RMB 0.42 basic and diluted earnings per share against RMB 33,631,000 or RMB 0.41 basic and diluted earnings per share a year ago. Operating cash flow increased to RMB 169.0 million ($27.9 million), compared to RMB 144.1 million in the prior year period. For the nine months, the company reported revenue of RMB 420,942,000 against RMB 393,112,000 a year ago. Operating income was RMB 167,913,000 against RMB 158,567,000 a year ago. Income before income tax was RMB 138,392,000 against RMB 124,607,000 a year ago. Net income attributable to the company was RMB 92,364,000 or RMB 1.14 basic and diluted earnings per share against RMB 89,419,000 or RMB 1.17 basic and diluted earnings per share a year ago. Net cash provided by operating activities was RMB 398,616,000.

China Cord Blood Corporation Presents at 26th Annual ROTH Conference, Mar-11-2014 05:30 PM

China Cord Blood Corporation Presents at 26th Annual ROTH Conference, Mar-11-2014 05:30 PM. Venue: The Ritz Carlton, 1 Ritz Carlton Dr, Dana Point, CA 92629, United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CO:US $4.29 USD +0.01

CO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CO.
View Industry Companies
 

Industry Analysis

CO

Industry Average

Valuation CO Industry Range
Price/Earnings 17.8x
Price/Sales 4.0x
Price/Book 1.3x
Price/Cash Flow 16.4x
TEV/Sales NM Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHINA CORD BLOOD CORP, please visit www.chinacordbloodcorp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.